These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9231320)

  • 41. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects.
    Coppola G; Verrotti A; Resicato G; Ferrarelli S; Auricchio G; Operto FF; Pascotto A
    Epilepsy Behav; 2008 Feb; 12(2):253-6. PubMed ID: 17962081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia.
    Kremer I; Vass A; Gorelik I; Bar G; Blanaru M; Javitt DC; Heresco-Levy U
    Biol Psychiatry; 2004 Sep; 56(6):441-6. PubMed ID: 15364042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Add-on lamotrigine treatment and plasma glutamate levels in epilepsy: relation to treatment response.
    Paraskevas GP; Triantafyllou NI; Kapaki E; Limpitaki G; Petropoulou O; Vassilopoulos D
    Epilepsy Res; 2006 Aug; 70(2-3):184-9. PubMed ID: 16762531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.
    Gillham R; Kane K; Bryant-Comstock L; Brodie MJ
    Seizure; 2000 Sep; 9(6):375-9. PubMed ID: 10985991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lamotrigine versus carbamazepine in epilepsy.
    Eeg-Olofsson O
    Lancet; 1995 May; 345(8960):1300; author reply 1300-1. PubMed ID: 7746065
    [No Abstract]   [Full Text] [Related]  

  • 48. Lamotrigine versus carbamazepine in epilepsy.
    Reynolds EH
    Lancet; 1995 May; 345(8960):1300; author reply 1300-1. PubMed ID: 7746066
    [No Abstract]   [Full Text] [Related]  

  • 49. Refractory Self-Injurious Behavior in Severe Intellectual Disability Responsive to Topiramate: A Case Report.
    Hamm B; Khokhar N; Jimenez XF
    Psychosomatics; 2017; 58(2):209-212. PubMed ID: 28189287
    [No Abstract]   [Full Text] [Related]  

  • 50. Clomipramine treatment for self-injurious behavior of individuals with mental retardation: a double-blind comparison with placebo.
    Lewis MH; Bodfish JW; Powell SB; Parker DE; Golden RN
    Am J Ment Retard; 1996 May; 100(6):654-65. PubMed ID: 8735578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characteristics of stereotypic movement disorder and self-injurious behavior assessed with the Diagnostic Assessment for the Severely Handicapped (DASH-II).
    Matson JL; Hamilton M; Duncan D; Bamburg J; Smiroldo B; Anderson S; Baglio C
    Res Dev Disabil; 1997; 18(6):457-69. PubMed ID: 9403928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of rationalizing drug treatment of patients with epilepsy and mental retardation.
    Beghi E; Bollini P; Di Mascio R; Cerisola N; Merloni T; Manghi E
    Dev Med Child Neurol; 1987 Jun; 29(3):363-9. PubMed ID: 3596072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidisciplinary assessment and treatment of self-injurious behavior in autism spectrum disorder and intellectual disability: integration of psychological and biological theory and approach.
    Minshawi NF; Hurwitz S; Morriss D; McDougle CJ
    J Autism Dev Disord; 2015 Jun; 45(6):1541-68. PubMed ID: 25395094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dramatic Response After Lamotrigine in a Patient With Epileptic Encephalopathy and a De NovoCACNA1A Variant.
    Byers HM; Beatty CW; Hahn SH; Gospe SM
    Pediatr Neurol; 2016 Jul; 60():79-82. PubMed ID: 27212419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of lamotrigine treatment in epileptic psychosis.
    De León OA; Furmaga KM
    J Clin Psychopharmacol; 1999 Apr; 19(2):186-8. PubMed ID: 10211924
    [No Abstract]   [Full Text] [Related]  

  • 56. The structure and correlates of self-injurious behavior in an institutional setting.
    Saloviita T
    Res Dev Disabil; 2000; 21(6):501-11. PubMed ID: 11153832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lamotrigine in two cases of Rett syndrome.
    Kumandas S; Caksen H; Ciftçi A; Oztürk M; Per H
    Brain Dev; 2001 Jul; 23(4):240-2. PubMed ID: 11377003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stress and self-injurious behavior; hormonal and serotonergic parameters in mentally retarded subjects.
    Verhoeven WM; Tuinier S; van den Berg YW; Coppus AM; Fekkes D; Pepplinkhuizen L; Thijssen JH
    Pharmacopsychiatry; 1999 Jan; 32(1):13-20. PubMed ID: 10071178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Psychopharmacological therapy of self-injurious behavior in mentally retarded individuals].
    Hässler F; Fegert JM
    Nervenarzt; 1999 Nov; 70(11):1025-8. PubMed ID: 10603598
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The evolution of self-injurious behaviors in people with intellectual disability and epilepsy: A follow-up study.
    Buono S; Zagaria T; Recupero M; Elia M; Kerr M; Di Nuovo S; Ferri R
    Seizure; 2020 Nov; 82():99-104. PubMed ID: 33045542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.